SCHEMBL5830296

SCHEMBL5830296

C[CH]c1ccc2cccc3c4cccc5cccc(c1c23)c54

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
HPGD P15428 7/20 0.52
HSD17B10 Q99714 7/20 0.52
CYP1A2 P05177 4/20 0.52
THRB P10828 1/20 0.52
ERBB2 P04626 1/20 0.42
FYN P06241 1/20 0.42
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
AHR P35869 1/20 0.42
TSHR P16473 6/20 0.41
CYP3A4 P08684 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
GUSB P08236 1/20 0.35
KDM4E B2RXH2 3/20 0.33
MAPT P10636 1/20 0.33
CYP2A6 P11509 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1618747 0.82 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
Ethane SCHEMBL27730225 0.81 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL3745503 0.80 CYP1A2 (0.52) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL1143168 0.80 ALDH1A1 (0.52) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL14892820 0.80 CYP1A2 (0.52) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL30791316 0.80 CYP1A2 (0.52) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL3625529 0.79 ALDH1A1 (0.54) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL1971147 0.78 HSD17B10 (0.48) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL28083404 0.77 HSD17B10 (0.54) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL27661971 0.77 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239745-A1 METHOD FOR SYNTHESIZING BILIRUBIN Bilix Co., Ltd. (KR) 2024-07-18 US disclosed
EP-4375280-A1 METHOD FOR SYNTHESIZING BILIRUBIN Bilix Co., Ltd. (KR) 2024-05-29 EP disclosed
EP-4371984-A1 METHOD FOR SYNTHESIZING BILIRUBIN Bilix Co., Ltd. (KR) 2024-05-22 EP disclosed
EP-4371985-A1 METHOD FOR SYNTHESIZING BILIRUBIN Bilix Co., Ltd. (KR) 2024-05-22 EP disclosed
US-7038086-B2 Vinyl polymer and organic electroluminescent device Shirota, Yasuhiko (JP) 2006-05-02 US disclosed
US-20040199016-A1 Vinyl polymer and organic electroluminescent device DAICEL CHEMICAL INDUSTRIES, LTD. 2004-10-07 US disclosed
US-6784318-B2 HEAT RESISTANCE YASUHIKO SHIROTA (JP) 2004-08-31 US disclosed
US-20030164678-A1 Vinyl polymer and organic electroluminescent device DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030164678-A1 Vinyl polymer and organic electroluminescent device HVCN1, VMP1, ELAVL1 ALDH1A1 648/4885HPGD 3551/4885HSD17B10 1483/4885
US-20240239745-A1 METHOD FOR SYNTHESIZING BILIRUBIN CYP7A1, UGT1A3, UGT1A1 ALDH1A1 225/4885HPGD 596/4885HSD17B10 339/4885
US-20040199016-A1 Vinyl polymer and organic electroluminescent device HVCN1, VMP1, ELAVL1 ALDH1A1 681/4885HPGD 3575/4885HSD17B10 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.